undamentalytics Newsletter
Sign in

Datameds AI, Inc. cash flow statement

In fiscal 2025, Datameds AI, Inc.'s operations generated −$10.9m of cash.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−1−11−14
Depreciation and amortisation132
Stock-based pay15529
Shares issued0——

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: MEDS vs MNDRDRIO vs MEDSMEDS vs WORX

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Datameds AI, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Datameds AI, Inc.